TargetRx

TargetRx

Founded 1999

Horsham, United States 28 employees Series D Total: $52.52M Biotechnology, Health Care +1

TargetRx is a US-based company founded in 1999, specializing in biotechnology, healthcare, and pharmaceutical industries. With a $15.05M Series D investment from New Enterprise Associates, Domain Associates, Quaker BioVentures, Montagu, Acacia Venture Partners in 28 April 2005, the company has been opportunistically positioned for growth. TargetRx has strategically positioned itself as a leader in understanding and leveraging the insights of over 75,000 physicians across 50 therapeutic categories. The company’s systematic surveys and research collaborations yield invaluable data on over 500 inline and pipeline brands, helping pharmaceutical and biotech companies optimize launch forecasting, physician targeting, message recall, sales force effectiveness, and more. Their commitment to moving beyond raw "data" to reveal true "insight" indicates a strong potential for continuous innovation and adaptability within the evolving healthcare landscape. With a long-standing history and a solid foundation of support from prominent investors, TargetRx emerges as a promising investment prospect for venture capitalists seeking exposure to the pharmaceutical and healthcare sectors. For potential investors looking to tap into the company's growth trajectory, TargetRx represents an enticing opportunity to participate in a forward-thinking enterprise poised for further expansion.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$15.05M	5	New Enterprise Associates, Domain Associates +3	28 Apr 2005
Series C	$15.47M	3	New Enterprise Associates, Domain Associates +1	03 Mar 2003
Series C	$10.00M	2	New Enterprise Associates, Domain Associates	21 Dec 2001
Series B	$12.00M	-		28 Jun 2000
Series A	Undisclosed	-		01 Jan 1999

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$15.05M

New Enterprise Associates, Domain Associates +3

28 Apr 2005

Series C

$15.47M

New Enterprise Associates, Domain Associates +1

03 Mar 2003

Series C

$10.00M

New Enterprise Associates, Domain Associates

21 Dec 2001

Series B

$12.00M

28 Jun 2000

Series A

Undisclosed

01 Jan 1999

FAQ About TargetRx

TargetRx. Know how. Welcome to TargetRx. Since 1999, we have systematically surveyed primary care and specialty care physicians in approximately 50 therapeutic categories to better understand physician attitudes, perceptions, needs, and motivations as they relate to patient care and prescribing....

TargetRx was founded in 1999.

TargetRx is headquartered in Horsham, United States.

TargetRx operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceutical research, physician survey, market research and product launch forecasting.

TargetRx has approximately 28 employees.

TargetRx has completed 5 funding rounds, raising a total of $52.52M. The latest funding stage is Series D.

Top alternatives and competitors to TargetRx include Alpha Sophia, Grand Medical Group AG, GMEP Medical Technology GmbH, Viking Healthcare Solutions, Life Science Strategy Group, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

TargetRx and Alpha Sophia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About TargetRx

Funding Rounds & Investors (5)

TargetRx Alternatives & Competitors

FAQ About TargetRx